Cargando…
Mapping of functional SARS-CoV-2 receptors in human lungs establishes differences in variant binding and SLC1A5 as a viral entry modulator of hACE2
BACKGROUND: The COVID-19 pandemic is an infectious disease caused by SARS-CoV-2. The first step of SARS-CoV-2 infection is the recognition of angiotensin-converting enzyme 2 (ACE2) receptors by the receptor-binding domain (RBD) of the viral Spike (S) glycoprotein. Although the molecular and structur...
Autores principales: | , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9795807/ https://www.ncbi.nlm.nih.gov/pubmed/36584595 http://dx.doi.org/10.1016/j.ebiom.2022.104390 |
_version_ | 1784860339044614144 |
---|---|
author | Miluzio, Annarita Cuomo, Alessandro Cordiglieri, Chiara Donnici, Lorena Pesce, Elisa Bombaci, Mauro Conti, Matteo Fasciani, Alessandra Terracciano, Luigi Manganaro, Lara Toccafondi, Mirco Scagliola, Alessandra Oliveto, Stefania Ricciardi, Sara Grifantini, Renata De Francesco, Raffaele Abrignani, Sergio Manfrini, Nicola Biffo, Stefano |
author_facet | Miluzio, Annarita Cuomo, Alessandro Cordiglieri, Chiara Donnici, Lorena Pesce, Elisa Bombaci, Mauro Conti, Matteo Fasciani, Alessandra Terracciano, Luigi Manganaro, Lara Toccafondi, Mirco Scagliola, Alessandra Oliveto, Stefania Ricciardi, Sara Grifantini, Renata De Francesco, Raffaele Abrignani, Sergio Manfrini, Nicola Biffo, Stefano |
author_sort | Miluzio, Annarita |
collection | PubMed |
description | BACKGROUND: The COVID-19 pandemic is an infectious disease caused by SARS-CoV-2. The first step of SARS-CoV-2 infection is the recognition of angiotensin-converting enzyme 2 (ACE2) receptors by the receptor-binding domain (RBD) of the viral Spike (S) glycoprotein. Although the molecular and structural bases of the SARS-CoV-2-RBD/hACE2 interaction have been thoroughly investigated in vitro, the relationship between hACE2 expression and in vivo infection is less understood. METHODS: Here, we developed an efficient SARS-CoV-2-RBD binding assay suitable for super resolution microscopy and simultaneous hACE2 immunodetection and mapped the correlation between hACE2 receptor abundance and SARS-CoV-2-RBD binding, both in vitro and in human lung biopsies. Next, we explored the specific proteome of SARS-CoV-2-RBD/hACE2 through a comparative mass spectrometry approach. FINDINGS: We found that only a minority of hACE2 positive spots are actually SARS-CoV-2-RBD binding sites, and that the relationship between SARS-CoV-2-RBD binding and hACE2 presence is variable, suggesting the existence of additional factors. Indeed, we found several interactors that are involved in receptor localization and viral entry and characterized one of them: SLC1A5, an amino acid transporter. High-resolution receptor-binding studies showed that co-expression of membrane-bound SLC1A5 with hACE2 predicted SARS-CoV-2 binding and entry better than hACE2 expression alone. SLC1A5 depletion reduces SARS-CoV-2 binding and entry. Notably, the Omicron variant is more efficient in binding hACE2 sites, but equally sensitive to SLC1A5 downregulation. INTERPRETATION: We propose a method for mapping functional SARS-CoV-2 receptors in vivo. We confirm the existence of hACE2 co-factors that may contribute to differential sensitivity of cells to infection. FUNDING: This work was supported by an unrestricted grant from “Fondazione Romeo ed Enrica Invernizzi” to Stefano Biffo and by AIRC under MFAG 2021 - ID. 26178 project – P.I. Manfrini Nicola. |
format | Online Article Text |
id | pubmed-9795807 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-97958072022-12-28 Mapping of functional SARS-CoV-2 receptors in human lungs establishes differences in variant binding and SLC1A5 as a viral entry modulator of hACE2 Miluzio, Annarita Cuomo, Alessandro Cordiglieri, Chiara Donnici, Lorena Pesce, Elisa Bombaci, Mauro Conti, Matteo Fasciani, Alessandra Terracciano, Luigi Manganaro, Lara Toccafondi, Mirco Scagliola, Alessandra Oliveto, Stefania Ricciardi, Sara Grifantini, Renata De Francesco, Raffaele Abrignani, Sergio Manfrini, Nicola Biffo, Stefano eBioMedicine Articles BACKGROUND: The COVID-19 pandemic is an infectious disease caused by SARS-CoV-2. The first step of SARS-CoV-2 infection is the recognition of angiotensin-converting enzyme 2 (ACE2) receptors by the receptor-binding domain (RBD) of the viral Spike (S) glycoprotein. Although the molecular and structural bases of the SARS-CoV-2-RBD/hACE2 interaction have been thoroughly investigated in vitro, the relationship between hACE2 expression and in vivo infection is less understood. METHODS: Here, we developed an efficient SARS-CoV-2-RBD binding assay suitable for super resolution microscopy and simultaneous hACE2 immunodetection and mapped the correlation between hACE2 receptor abundance and SARS-CoV-2-RBD binding, both in vitro and in human lung biopsies. Next, we explored the specific proteome of SARS-CoV-2-RBD/hACE2 through a comparative mass spectrometry approach. FINDINGS: We found that only a minority of hACE2 positive spots are actually SARS-CoV-2-RBD binding sites, and that the relationship between SARS-CoV-2-RBD binding and hACE2 presence is variable, suggesting the existence of additional factors. Indeed, we found several interactors that are involved in receptor localization and viral entry and characterized one of them: SLC1A5, an amino acid transporter. High-resolution receptor-binding studies showed that co-expression of membrane-bound SLC1A5 with hACE2 predicted SARS-CoV-2 binding and entry better than hACE2 expression alone. SLC1A5 depletion reduces SARS-CoV-2 binding and entry. Notably, the Omicron variant is more efficient in binding hACE2 sites, but equally sensitive to SLC1A5 downregulation. INTERPRETATION: We propose a method for mapping functional SARS-CoV-2 receptors in vivo. We confirm the existence of hACE2 co-factors that may contribute to differential sensitivity of cells to infection. FUNDING: This work was supported by an unrestricted grant from “Fondazione Romeo ed Enrica Invernizzi” to Stefano Biffo and by AIRC under MFAG 2021 - ID. 26178 project – P.I. Manfrini Nicola. Elsevier 2022-12-28 /pmc/articles/PMC9795807/ /pubmed/36584595 http://dx.doi.org/10.1016/j.ebiom.2022.104390 Text en © 2022 The Authors https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Articles Miluzio, Annarita Cuomo, Alessandro Cordiglieri, Chiara Donnici, Lorena Pesce, Elisa Bombaci, Mauro Conti, Matteo Fasciani, Alessandra Terracciano, Luigi Manganaro, Lara Toccafondi, Mirco Scagliola, Alessandra Oliveto, Stefania Ricciardi, Sara Grifantini, Renata De Francesco, Raffaele Abrignani, Sergio Manfrini, Nicola Biffo, Stefano Mapping of functional SARS-CoV-2 receptors in human lungs establishes differences in variant binding and SLC1A5 as a viral entry modulator of hACE2 |
title | Mapping of functional SARS-CoV-2 receptors in human lungs establishes differences in variant binding and SLC1A5 as a viral entry modulator of hACE2 |
title_full | Mapping of functional SARS-CoV-2 receptors in human lungs establishes differences in variant binding and SLC1A5 as a viral entry modulator of hACE2 |
title_fullStr | Mapping of functional SARS-CoV-2 receptors in human lungs establishes differences in variant binding and SLC1A5 as a viral entry modulator of hACE2 |
title_full_unstemmed | Mapping of functional SARS-CoV-2 receptors in human lungs establishes differences in variant binding and SLC1A5 as a viral entry modulator of hACE2 |
title_short | Mapping of functional SARS-CoV-2 receptors in human lungs establishes differences in variant binding and SLC1A5 as a viral entry modulator of hACE2 |
title_sort | mapping of functional sars-cov-2 receptors in human lungs establishes differences in variant binding and slc1a5 as a viral entry modulator of hace2 |
topic | Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9795807/ https://www.ncbi.nlm.nih.gov/pubmed/36584595 http://dx.doi.org/10.1016/j.ebiom.2022.104390 |
work_keys_str_mv | AT miluzioannarita mappingoffunctionalsarscov2receptorsinhumanlungsestablishesdifferencesinvariantbindingandslc1a5asaviralentrymodulatorofhace2 AT cuomoalessandro mappingoffunctionalsarscov2receptorsinhumanlungsestablishesdifferencesinvariantbindingandslc1a5asaviralentrymodulatorofhace2 AT cordiglierichiara mappingoffunctionalsarscov2receptorsinhumanlungsestablishesdifferencesinvariantbindingandslc1a5asaviralentrymodulatorofhace2 AT donnicilorena mappingoffunctionalsarscov2receptorsinhumanlungsestablishesdifferencesinvariantbindingandslc1a5asaviralentrymodulatorofhace2 AT pesceelisa mappingoffunctionalsarscov2receptorsinhumanlungsestablishesdifferencesinvariantbindingandslc1a5asaviralentrymodulatorofhace2 AT bombacimauro mappingoffunctionalsarscov2receptorsinhumanlungsestablishesdifferencesinvariantbindingandslc1a5asaviralentrymodulatorofhace2 AT contimatteo mappingoffunctionalsarscov2receptorsinhumanlungsestablishesdifferencesinvariantbindingandslc1a5asaviralentrymodulatorofhace2 AT fascianialessandra mappingoffunctionalsarscov2receptorsinhumanlungsestablishesdifferencesinvariantbindingandslc1a5asaviralentrymodulatorofhace2 AT terraccianoluigi mappingoffunctionalsarscov2receptorsinhumanlungsestablishesdifferencesinvariantbindingandslc1a5asaviralentrymodulatorofhace2 AT manganarolara mappingoffunctionalsarscov2receptorsinhumanlungsestablishesdifferencesinvariantbindingandslc1a5asaviralentrymodulatorofhace2 AT toccafondimirco mappingoffunctionalsarscov2receptorsinhumanlungsestablishesdifferencesinvariantbindingandslc1a5asaviralentrymodulatorofhace2 AT scagliolaalessandra mappingoffunctionalsarscov2receptorsinhumanlungsestablishesdifferencesinvariantbindingandslc1a5asaviralentrymodulatorofhace2 AT olivetostefania mappingoffunctionalsarscov2receptorsinhumanlungsestablishesdifferencesinvariantbindingandslc1a5asaviralentrymodulatorofhace2 AT ricciardisara mappingoffunctionalsarscov2receptorsinhumanlungsestablishesdifferencesinvariantbindingandslc1a5asaviralentrymodulatorofhace2 AT grifantinirenata mappingoffunctionalsarscov2receptorsinhumanlungsestablishesdifferencesinvariantbindingandslc1a5asaviralentrymodulatorofhace2 AT defrancescoraffaele mappingoffunctionalsarscov2receptorsinhumanlungsestablishesdifferencesinvariantbindingandslc1a5asaviralentrymodulatorofhace2 AT abrignanisergio mappingoffunctionalsarscov2receptorsinhumanlungsestablishesdifferencesinvariantbindingandslc1a5asaviralentrymodulatorofhace2 AT manfrininicola mappingoffunctionalsarscov2receptorsinhumanlungsestablishesdifferencesinvariantbindingandslc1a5asaviralentrymodulatorofhace2 AT biffostefano mappingoffunctionalsarscov2receptorsinhumanlungsestablishesdifferencesinvariantbindingandslc1a5asaviralentrymodulatorofhace2 |